Market revenue in 2023 | USD 197.2 million |
Market revenue in 2030 | USD 283.4 million |
Growth rate | 5.3% (CAGR from 2023 to 2030) |
Largest segment | Carbohydrates |
Fastest growing segment | Polyols |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Specialty Excipients/Others, Solubilizes & Surfactants/Emulsifiers, Polyols, Carbohydrates |
Key market players worldwide | Merck KGaA, Basf SE, Associated British Foods PLC, IMCD NV, Clariant AG, Evonik Industries AG, Colorcon, Sigachi, Spectrum Chemical Manufacturingrp, Roquette America, DFE Pharma, J. Rettenmaier & Söhne |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical excipients market will help companies and investors design strategic landscapes.
Carbohydrates was the largest segment with a revenue share of 35.75% in 2023. Horizon Databook has segmented the Germany biopharmaceutical excipients market based on specialty excipients/others, solubilizes & surfactants/emulsifiers, polyols, carbohydrates covering the revenue growth of each sub-segment from 2018 to 2030.
Germany has generated highest revenue in the Europe biopharmaceutical excipients market in 2018 and has maintained this trend throughout the forecast period. This is attributed to its strong position in the European pharmaceutical market responsible for approximately 23% of the same while ranking third globally.
The Drug Commission of the German Medical Association announced in 2008 that biosimilars can be considered as potent therapeutic alternative. Increasing number of physicians becoming primary users of biosimilars have propelled the demand for the same in Germany.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany biopharmaceutical excipients market , including forecasts for subscribers. This country databook contains high-level insights into Germany biopharmaceutical excipients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account